Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2026-04-03 @ 10:48 AM
Study NCT ID:
NCT02561832
Status:
TERMINATED
Last Update Posted:
2019-02-20
First Post:
2015-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-06
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-13
First Submit QC Date:
None
Study First Post Date:
2015-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-10
Results First Submit QC Date:
None
Results First Post Date:
2019-02-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-15
Last Update Post Date:
2019-02-20
Last Update Post Date Type:
ACTUAL